U.S. Markets close in 49 mins

2-Day 4th Annual Next Gen Immuno-Oncology Congress: London, United Kingdom - March 12-13, 2020

DUBLIN, Dec. 30, 2019 /PRNewswire/ -- The "Next Gen Immuno-Oncology Congress" conference has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

Last year, the 3rd Annual Next Gen Immuno-Oncology Congress discussed the latest updates in the development of Monoclonal Antibodies, ADC's, Bispecific Antibodies, Immune Checkpoint inhibitors, and Cellular Therapy. The Congress also focused on various combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccine development and personalized immunotherapy.

  • 30+ experts from academia and industry will be presenting their current work in Immuno-Oncology, Latest updates on regulatory guidelines and approvals, Validation markers for tumor-derived T-cell subpopulations, NextGen T-Cell and CAR-T Cell therapy, Personalized Medicine, Biomarkers and Cancer Immunotherapy
  • Opportunity to develop long-lasting business relationships and networking opportunities with researchers, scientists, clinicians, academicians and professionals from Pharmaceutical companies, Bio-pharma companies, Universities, and Research institutes.
  • Over 20 presentations, round-tables, and panel discussions focused on the key opportunities and challenges in biomarker research, Validation methods and innovative tools in IO Discovery, Oral T-Cell Therapies for the Treatment of Cancer Patients and Discovery of novel bispecific antibody molecules to boost anti-tumor immunity.

This year, the 4th Annual Next Gen Immuno-Oncology Congress will focus on New Immuno-Oncology Developments, Immune Checkpoint Inhibitors & Combination Therapy, Updates in Antibody development & New Antibody formats, NextGen T-Cell & CAR-T Cell therapy, Personalized Medicine, Biomarkers and Cancer Immunotherapy.

This two-day event will invite 100+ Immuno-Oncology professionals, 30+ expert speakers, and 15+ solution/technology providers to a unique platform to deliver niche buyer-seller ecosystem in the biomarker Industry.

For more information about this conference visit https://www.researchandmarkets.com/r/j5cf4u

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision

View original content:http://www.prnewswire.com/news-releases/2-day-4th-annual-next-gen-immuno-oncology-congress-london-united-kingdom---march-12-13-2020-300979837.html

SOURCE Research and Markets